Home > Our History
Our History
20 Years of DCVMN: A Timeline
WHO meeting of International Public Sector Vaccinology Institutions in Geneva on March 2000, called vaccine manufacturers from developing countries to form a constituency and holds 1st AGM in Noordwick.
DCVMN met on 26–27 April 2001 in Bandung, Indonesia, formalizing strategic objectives and governance and grows to 20 members.
A DCVMN member engaged in an historical Project to develop a vaccine for the African meningitis belt countries.
Success in increasing access to HepB and Hib containing DPT combination vaccines with the help from technology transfer from The Netherlands Vaccine Institute (NVI) to three DCVMN member companies: Bio Farma, Serum Institute of India and Biological E.
DCVMN had 19 members in 2004
DCVMN members engaged on the Global Action Plan for Influenza Vaccines. In response to the human-to-human transmission of H5N1, WHO called to strengthen the capacity of developing countries to produce influenza vaccines.
The Network’s main strategic priority, to increase access to combination vaccines containing DPT-HepatitisB-Haemophilus influenzae type b (Hib), has been fulfilled due, in part, to the transfer of conjugation technology from The Netherlands Vaccine Institute to various manufacturers.
The first fully liquid Pentavalent (DTwPHepBHib) for Childhood vaccination was launched by Panacea Biotec and granted WHO pre-qualification for Gavi supply.
DCVMN had 19 members; 7 members with WHO pre-qualified vaccines.
DCVMN members – Serum Institute of India, China National Biotec Group, Panacea, Beijing Minhai, LG Chem - engaged in the Sabin-IPV vaccine development upon request of WHO.
WHO declares the start of 2009 influenza pandemic
In the context of the H1N1 Pandemic, three DCVMs readied an influenza vaccine for global use in a record time of 9 months.
Last endemic case of rubella in the Americas observed in February 2009, with the help of the consistent supply of Rubella containing vaccines from Serum Institute of India and Biomanguinhos
DCVMN had 23 members
The group A meningitis vaccine produced by a DCVM, SII, was approved for use in Sub-Saharan Africa, resulting in 100 million people being vaccinated.
DCVMN had 22 members
On 13 January 2011, India recorded its last case of poliomyelitis.
The first Hepatitis E Vaccine produced by INNOVAX was approved in China.
The DCVMN International Secretariat in Switzerland was formally established on February 15th, 2012 as a not-for-profit international association of vaccine manufacturers.
Japanese encephalitis vaccines from DCVMs -Chengdu Biological Products Institute and from Biological E - received WHO pre-qualification.
Bharat Biotech launched the first typhoid conjugate vaccine.
Executives of the Developing Countries Vaccine Manufacturers Network met Dr. Margaret Chan, WHO Director General.
The first inactivated Enterovirus 71 vaccine was launched by IMBCAMS and approved for the distribution to the Chinese market.
The first fully liquid hexavalent vaccine based on whole-cell Pertussis was produced by Panacea Biotec.
Two new Rotavirus vaccines from Serum Institute of India and Bharat Biotech received WHO pre-qualification.
A pneumococcal vaccine produced by Serum Institute of India received WHO pre-qualification. Since 2008, SII and PATH have collaborated to develop the vaccine, with support from the Bill & Melinda Gates Foundation.
On 25th August 2020, the Africa Regional Certification Commission certified the WHO African Region as wild polio-free after four years without a case.
The first vaccine granted WHO Emergency Use. WHO listed the nOPV2 vaccine from Bio Farma, Indonesia, for emergency use to address cases of a vaccine-derived polio strain in African and East Mediterranean countries.
Partners:
DCVMN
DCVMN is a voluntary public health driven alliance of vaccine manufacturers from developing countries that aims to make a consistent supply of high quality vaccines that are accessible to protect people against known and emerging infectious diseases globally.
Become a member footer
Become a member Register